BioCapital Europe 2023

Richard Hausmann, CEO of Combinostics, will discuss our company history and development of the cNeuro® suite, our complete AI software solution that supports entire patient care pathways of major neurological disorders, including early detection, differentiation of diagnosis, treatment planning, and monitoring. The platform includes the cMRI™ and cDSI™ applications, pending cPET™ application (WIP), industry-first Dementia Differential Analysis report, and clinically focused cMRI reports for dementia, multiple sclerosis, traumatic brain injuries, and epilepsy. 

BioCapital Europe 2023

March 9, 2023
Presentation at 4:20 pm CET

Richard Hausmann,
CEO of Combinostics

Recent News & Events

RSNA 2023

Attending RSNA 2022? Stop by booth 3938 in the AI Showcase to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.

Read More »